Browse by Title

Type here to filter the list

C
C: Ablation Techniques for localized RCC
Favorite

Karim Bensalah ### 1828448###Speaker#########
Speaker: Karim Bensalah
###
Chromophobe RCC
Favorite

Stéphane Oudard, PhD, MD (he/him/his) – Georges Pompidou Hospital ### 1828468###Speaker###chief of oncology department###Georges Pompidou Hospital###
Speaker: Stéphane Oudard, PhD, MD (he/him/his) – Georges Pompidou Hospital
### he/him/his
Circulating T cell activation as predictor of therapy response
Favorite

Haydn Kissick, PhD – Emory University ### 1828471###Speaker###Assistant Professor###Emory University###
Speaker: Haydn Kissick, PhD – Emory University
###
Collecting Duct and Renal Medullary Carcinoma
Favorite

Giuseppe Procopio, MD – Fondazione IRCCS Istituto Nazionale Tumori ### 1570727###Speaker###Director of Genitourinary Unit###Fondazione IRCCS Istituto Nazionale Tumori###
Speaker: Giuseppe Procopio, MD – Fondazione IRCCS Istituto Nazionale Tumori
###
Oral Abstract: Cross-trial propensity score weighted analysis of nivolumab plus ipilimumab versus nivolumab monotherapy for patients with untreated advanced renal cell carcinoma
Favorite

Michael B. Atkins, MD (he/him/his) – Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA. ### 1777872###Lead Author###Vice Chair of Department of Medical Oncology###Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.###
Lead Author: Michael B. Atkins, MD (he/him/his) – Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.
### he/him/his
Cytoreductive Nephrectomy in Metastatic Disease: who, how, when?
Favorite

Arnaud Mejean, MD, PhD (he/him/his) – HEGP, APHP, Université Paris-Centre ### 1828450###Speaker###Chairman###HEGP, APHP, Université Paris-Centre###
Speaker: Arnaud Mejean, MD, PhD (he/him/his) – HEGP, APHP, Université Paris-Centre
### he/him/his